Rajesh Kumar
Stock Analyst at HSBC
(3.26)
# 938
Out of 4,839 analysts
21
Total ratings
60%
Success rate
13.16%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Downgrades: Reduce | $1,150 → $700 | $724.95 | -3.44% | 2 | Apr 28, 2025 | |
| IQV IQVIA Holdings | Downgrades: Hold | $260 → $160 | $137.29 | +16.54% | 1 | Apr 25, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $33.59 | +25.04% | 1 | Apr 25, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $185 | $181.80 | +1.76% | 3 | Jun 5, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $398.28 | +68.22% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $186.81 | +49.88% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $302.98 | +51.83% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $16.55 | -21.45% | 1 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $47.00 | +12.77% | 2 | Oct 27, 2023 | |
| MRNA Moderna | Initiates: Reduce | $97 | $25.80 | +275.97% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $99.09 | +25.14% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $23.04 | +117.01% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $76.98 | +59.78% | 1 | Jul 14, 2023 |
Eli Lilly and Company
Apr 28, 2025
Downgrades: Reduce
Price Target: $1,150 → $700
Current: $724.95
Upside: -3.44%
IQVIA Holdings
Apr 25, 2025
Downgrades: Hold
Price Target: $260 → $160
Current: $137.29
Upside: +16.54%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $33.59
Upside: +25.04%
AbbVie
Jun 5, 2024
Upgrades: Buy
Price Target: $185
Current: $181.80
Upside: +1.76%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $398.28
Upside: +68.22%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $186.81
Upside: +49.88%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $302.98
Upside: +51.83%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $16.55
Upside: -21.45%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $47.00
Upside: +12.77%
Moderna
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $25.80
Upside: +275.97%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $99.09
Upside: +25.14%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $23.04
Upside: +117.01%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $76.98
Upside: +59.78%